Citadel Advisors - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is and the CUSIP is 29269A952. A total of 3 filers reported holding ENDOCYTE INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ENDOCYTE INC
ValueSharesWeighting
Q2 2016$44,000
-10.2%
13,700
-13.3%
0.00%
Q1 2016$49,000
-56.6%
15,800
-44.2%
0.00%
Q4 2015$113,000
+59.2%
28,300
+81.4%
0.00%
Q3 2015$71,000
+16.4%
15,600
+33.3%
0.00%
Q2 2015$61,000
-55.1%
11,700
-46.1%
0.00%
Q1 2015$136,000
-60.3%
21,700
-60.3%
0.00%
Q4 2014$343,000
-11.8%
54,600
-14.6%
0.00%
Q3 2014$389,000
-33.0%
63,900
-27.6%
0.00%
-100.0%
Q2 2014$581,000
-22.3%
88,200
+180.9%
0.00%0.0%
Q1 2014$748,000
+1338.5%
31,400
+540.8%
0.00%
Q4 2013$52,0004,9000.00%
Other shareholders
ENDOCYTE INC shareholders Q3 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 308,600$1,876,0000.03%
SABBY MANAGEMENT, LLC 863$525,0000.02%
Citadel Advisors 63,900$389,0000.00%
View complete list of ENDOCYTE INC shareholders